Multi-location, 24/7, profitable high-complexity laboratory generating $9.4M in revenue, operating in Texas and Arkansas. Operating since 2019, it processes approximately 4,000 PCR samples per month and has little to no debt. This is a turnkey opportunity with established operations and strong current volume.
FINANCIAL HIGHLIGHTS (FY2025)
- Revenue: $9.41 Million
- Gross Profit: $5.22 Million
- Gross Margin: 55.5%
- 73% Year-over-Year Revenue Growth
- Approximately 3,800 PCR Samples Per Month
- ~$2.49 Million in Owned Laboratory Equipment
BUSINESS CHARACTERISTICS
- 24/7 multi-state lab operations
- High-throughput molecular PCR testing
- Diversified payer mix including Medicare and major commercial carriers
- Established billing infrastructure and revenue cycle management
- No material equipment debt
STRATEGIC POSITIONING
- Processing significantly higher PCR volumes than comparable independent regional labs
- Scalable infrastructure with meaningful operating leverage
- Licensed, high-barrier laboratory platform
- Clear pathway to 6,000+ samples per month target
- Margin expansion potential through procurement optimization and AR tightening
INVESTMENT RATIONALE
- ~1.0× Revenue entry multiple
- Asset-supported platform with tangible equipment base
- Non-discretionary healthcare demand profile
- Multi-state licensure reduces replication risk
- Positioned for strategic tuck-in or platform expansion
